We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

Drug Compounding Bill to Clarify the FDA's Role, Introduce New Regulatory Limits

19 November 2013

Pharmaceutical and Biotechnology Alert

Congress has passed a new law clarifying the relationship between the U.S. Food and Drug Administration (FDA) and pharmacy compounding facilities. The text of the bill as introduced in the Senate and was passed by voice vote without substantive changes.

Read More: Drug Compounding Bill to Clarify the FDA's Role, Introduce New Regulatory Limits

The team

Loading data